Tenable appoints Steve Vintz and Mark Thurmond as Co-CEOs
Tenable®, the exposure management company, recently announced that its Board of Directors has unanimously appointed Steve Vintz and Mark Thurmond as co-Chief Executive Officers on a permanent basis.
Following an extensive search process that considered both internal and external candidates, the Board concluded that Vintz and Thurmond are best positioned to move the company forward. The decision reflects the Board's confidence in the strength of their leadership following a successful interim period during which they drove significant operational and strategic momentum. The Board also intends to appoint Vintz and Thurmond to the Board immediately following the company's annual shareholder meeting to be held on May 14, 2025.
Vintz, Tenable's Chief Financial Officer since 2014, and Thurmond, who has served as Chief Operating Officer since 2020, bring deep industry and operational experience. Under the co-CEO structure, Vintz will oversee product, cyber security, corporate development and all general and administrative functions, while Thurmond will oversee GTM functions including sales, professional services, technical support, marketing, and customer success. Together, they will continue to guide the company's mission to help organisations understand and reduce cyber risk across their modern attack surfaces.
'Mark and Steve have demonstrated exceptional leadership and alignment during their time as interim co-CEOs', said Art Coviello, Chairman of the Tenable Board of Directors. 'Their collaborative leadership style, deep industry knowledge, and customer-first mindset have already created strong results. We are confident in their ability to continue driving innovation and long-term value for all stakeholders'.
Under their interim leadership, Tenable has expanded its customer footprint, with strong adoption of the Tenable One Exposure Management platform and growing momentum behind Tenable Cloud Security. They also completed the strategic acquisition of Vulcan Cyber, advancing Tenable's product roadmap with the expected launch of a significantly expanded version of Tenable One that we believe will be the most comprehensive exposure management platform on the market.
'We are honoured to lead Tenable as co-CEOs and energized by the opportunity ahead', said Vintz and Thurmond in a joint statement. 'We have tremendous belief in Tenable's mission, team and market position, and we're excited to build on our momentum to deliver meaningful outcomes for our customers, employees and shareholders'.
Coviello, a respected cybersecurity leader, will remain Chairman of the Board. Additionally, Steve Vintz will continue to serve as Chief Financial Officer, while the company conducts a CFO search.
Image Credit: Tenable
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
TECHx
an hour ago
- TECHx
AmiViz Ranked Among Top Tech Workplaces in GCC
Home » Tech Value Chain » Distributors » AmiViz Ranked Among Top Tech Workplaces in GCC AmiViz, a cybersecurity-focused value-added distributor based in the Middle East, has been ranked 22nd on the 2025 list of Best Workplaces in Technology in the GCC region. The ranking was announced by Great Place to Work®, a global authority on workplace culture. This recognition highlights AmiViz's strong commitment to creating an inclusive, empowering, and innovation-driven work environment. It reflects the company's efforts to foster a culture where trust, collaboration, and professional growth are a priority. According to Great Place to Work®, the ranking is based on employee feedback collected through confidential surveys. It also includes an in-depth assessment of the company's HR practices, leadership involvement, and focus on employee well-being. AmiViz stood out for promoting a transparent and agile workplace. The company was recognized for encouraging employees to excel and contribute meaningfully to its mission. The company reported that its people-centric approach remains a core value. It continues to invest in employee development and well-being while navigating a rapidly evolving tech landscape. AmiViz promotes continuous learning and upskilling The company values diversity and encourages innovation Ilyas Mohammed, Chief Operating Officer at AmiViz, expressed pride in the achievement. He stated, 'Being recognized among the top workplaces in technology across the GCC is an honour that validates our belief that a strong company culture is a catalyst for sustainable growth. Our team is at the heart of everything we do, and this recognition is a reflection of their passion, dedication, and the values we live by every day.' The company revealed that this recognition comes during a phase of strategic expansion. It also highlights AmiViz's ability to scale while maintaining its core values. AmiViz continues to strengthen its position in cybersecurity distribution across the region. The company emphasized that its workplace culture plays a key role in this success. This announcement sends a clear message to employees, partners, and stakeholders. AmiViz is not only a leader in cybersecurity solutions but also a company that values its people as its greatest asset.
Arabian Post
5 hours ago
- Arabian Post
MediLink Therapeutics Taps Major Banks for Hong Kong Float
MediLink Therapeutics Ltd. is preparing to launch an initial public offering in Hong Kong, having secured China International Capital Corp., JPMorgan Chase & Co. and Morgan Stanley as its lead advisers, according to people with knowledge of the matter. The move comes as the clinical-stage biotech firm seeks to capitalise on growing investor interest in advanced tumour-targeting therapies and consolidate its platform of antibody‑drug conjugates. Founded in 2020 and headquartered in Suzhou with R&D operations in Shanghai and Boston, MediLink has developed a proprietary ADC technology known as TMALIN®. The platform facilitates precise delivery of cytotoxic agents to tumour cells, with the intention of widening therapeutic windows for solid tumour treatments. Its pipeline includes programs that have advanced to clinical stages in both China and the United States, supported by a Series B financing round of approximately USD 70 million in 2022. MediLink's strategic engagement of three underwriters reflects heightened confidence in anchor investors and broader syndication. China International Capital Corp. brings deep roots in Chinese capital markets and extensive IPO experience in the biotech sector. JPMorgan and Morgan Stanley add global banking heft and access to international investors. ADVERTISEMENT CICC itself is emerging as a top-tier sponsor for Hong Kong listings. It led or co-led 19 IPOs for Chinese corporates last year, raising USD 3.84 billion, positioning it as a dominant force amid market revival. The engagement of internationally renowned banks alongside CICC is likely aimed at boosting MediLink's valuation and widening investor interest both locally and abroad. While IPO details remain confidential, analysts suggest MediLink could seek a valuation in the mid‑to‑high hundreds of millions of dollars. That would reflect both the advanced stage of its pipeline and prevailing market multiples for ADC developers. Comparable biotech flotations in Hong Kong and the U.S. have reflected growing appetite for oncology-focused platforms. Alongside listing ambitions, MediLink continues to advance its clinical and licensing goals. In March it unveiled preclinical data at the American Association for Cancer Research annual meeting; earlier in the year it received FDA clearance for its IND application for YL217, its lead candidate. YL201, another programme, received Breakthrough Therapy Designation in January for treatment of recurrent/metastatic nasopharyngeal carcinoma. The company has also pursued strategic licensing agreements with global pharmaceutical firms to expand development and commercialisation capabilities. A licensing deal under discussion ahead of the IPO is believed aimed at enhancing distribution reach while reinforcing MediLink's balance sheet. The IPO effort is part of a broader resurgence in biotech listings in Hong Kong, where authorities have eased regulations to attract innovation-driven offerings. CICC and other banks have ramped up support for ADC and gene therapy companies, signalling a turning point after a lull in listings. ADVERTISEMENT MediLink's choice of banks aligns with a wider trend: CICC has co-sponsored blockbuster floats including the forthcoming mega‑IPO of CATL, while banks like Goldman Sachs and Morgan Stanley have also participated. In this context, MediLink is positioning itself to tap both deep domestic networks and international capital. Stakeholder sentiment appears optimistic. MediLink's management team, comprised of co‑founders Tony Xue and Jiaqiang Cai alongside C‑suite leaders experienced in drug development and financial strategy, has overseen steady progress in its ADC pipeline and established global partnerships. Jason Li's appointment as CFO in 2023 reportedly strengthened the company's capital market readiness. Market observers highlight challenges ahead. ADC development remains capital-intensive, clinical risks high, and competition fierce among domestic and international peers. Success will hinge on late‑stage data and licensing traction. At the same time, geopolitical tensions and volatility in Hong Kong equity markets may affect investor sentiment. MediLink must also navigate post‑IPO obligations, including regulatory reporting and corporate governance under Hong Kong's Main Board requirements. Mitigating execution risk will be critical, underscoring the role of its chosen bankers in underwriting diligence and market support. Analysts describe the listing as a pivotal moment: it offers the backing to fund Phase II/III efforts while elevating MediLink's corporate profile. For banks, it reinforces Hong Kong's appeal as a biotech capital market when compared with established centres like Nasdaq. With its IPO process underway, MediLink now awaits market timing and regulatory clearances before formally filing a prospectus. The company is expected to continue advancing clinical data, strengthening licensing ties, and preparing investor materials aligned with regulatory requirements.
TECHx
2 days ago
- TECHx
Fortinet Unveils AI-Powered Cybersecurity Upgrades
Home » Emerging technologies » Cyber Security » Fortinet Unveils AI-Powered Cybersecurity Upgrades Fortinet® (NASDAQ: FTNT), announced new upgrades to its data and productivity security portfolio. The company revealed enhancements to FortiMail through the launch of the FortiMail Workspace Security suite. These updates establish FortiMail as a highly customizable email security platform. It now extends protection beyond email to browsers and collaboration tools. This includes platforms like Microsoft 365, Teams, Google Workspace, and Slack. Fortinet reported that the new capabilities provide broader, AI-powered protection across digital work environments. These advancements also include improvements to FortiDLP, the company's data loss prevention and insider risk management solution. According to Nirav Shah, Senior Vice President of Products and Solutions at Fortinet, 'Cybercriminals are targeting users and using tools like FraudGPT, BlackmailerV3, and ElevenLabs to automate threats.' He added that Fortinet's enhanced AI-powered security tools help defend against these sophisticated attacks. The upgrades offer: AI-driven defense across email, browser, and collaboration environments Managed 24×7 incident response to reduce pressure on SOC teams Fortinet highlighted that today's hybrid workforce increases the attack surface due to reliance on SaaS and collaboration tools. The company's 2025 Global Threat Landscape Report shows a rise in AI-powered cybercrime, including phishing and impersonation attempts. FortiMail now includes flexible deployment across appliances, virtual machines, SaaS, and hosted services. It supports multiple operating modes such as gateway, server, ICES, and hybrid. The platform integrates with Perception Point, recognized in the 2024 Gartner® Magic Quadrant™ for Email Security. The FortiMail Workspace Security suite helps detect evasive attacks and block threats hidden in shared files or malicious links. It also improves visibility into user behavior across cloud environments. FortiDLP adds secure data flow capabilities with lineage and sequence detection. It tracks how data is used and manipulated by users. It also flags suspicious behavior for further investigation. Fortinet reported that this helps prevent data exposure to unsanctioned SaaS and GenAI platforms. Fortinet stated that these enhancements deliver a unified cybersecurity approach. The company aims to provide visibility, control, and faster threat response in today's complex digital landscape.
